Oct 16

Blood pressure and fluid retention drugs recalled over cancer concerns

Posted in: Today's Chili

The FDA has published a new recall advisory from Lupin Pharmaceuticals over two different drugs: Hydrochlorothiazide and Irbesartan. The company, which stopped marketing these particular drugs in January, says it is recalling the batches due to potentially higher than acceptable levels of an impurity called N-nitrosoirbesartan. The recall covers the pharmaceutical company’s Irbesartan Tablets USP in 75mg, 150mg, and 300mg … Continue reading

No Responses to “Blood pressure and fluid retention drugs recalled over cancer concerns”

Post a Comment